TURNING INTERMITTENT REGIMENS INTO DAILY REGIMENS USING BLISTER-PACKS - AN EXPLORATION IN MURINE TUBERCULOSIS

被引:6
作者
GUY, A [1 ]
DICKINSON, JM [1 ]
MITCHISON, DA [1 ]
机构
[1] ROYAL POSTGRAD MED SCH,DEPT INFECT DIS & BACTERIOL,DU CANE RD,LONDON W12 ONN,ENGLAND
来源
TUBERCLE AND LUNG DISEASE | 1993年 / 74卷 / 05期
关键词
D O I
10.1016/0962-8479(93)90105-7
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Setting: Blisterpacks might be used to present low cost intermittent regimens while maintaining an easily remembered daily frequency of opening blisters, by alternating blisters containing 2 of the drugs of a 4-drug regimen with blisters containing the remaining 2 drugs. Objective: The efficacy of the alternating regimens was examined in murine tuberculosis. Design: 2 weeks after infection with Mycobacterium tuberculosis H37Rv, groups of mice were treated with rifampicin (R) 15 mg/kg, isoniazid (H) 25 mg/kg, pyrazinamide (Z) 300 mg/kg, ethambutol (E) 100 mg/kg three times weekly (RHZE3); RH/ZE, an alternating regimen of RH on days 1, 3 and 5 of the week and ZE on days 2, 4 and 6, RZ/HE or RE/HZ. Results: Spleen and lung bacillary counts at 7 and 12 weeks indicated large differences in the efficacy of the regimens: RZ/HE > RE/HZ > RHZE, > RH/ZE. Serum assays showed that Rifampicin (RMP) levels were much lower after HRZE and slightly lower after RZ, RE and RH than after R alone, whereas levels were similar when R was given before the remaining drugs; also, the absorption of Z was slightly increased by R. A second experiment used the same 4 regimens but gave R before other drugs. The organ colony forming units counts at 6 and 12 weeks were then similar. A third experiment examined continuation phase regimens of R3, R2, R2H-2 and R2H-6 given after daily RHZ treatment for 4 weeks. It found R2H-2 only slightly superior to R2H-6 and R, much better than R2. Conclusion: 1. Alternating initial phase regimens were as effective as conventional intermittent regimens. 2. R3H-6 might be an optimal continuation phase regimen for blisterpacks.
引用
收藏
页码:310 / 316
页数:7
相关论文
共 12 条
[1]  
[Anonymous], 1979, Tubercle, V60, P201
[2]   ACTIVITY OF 2 LONG-ACTING RIFAMYCINS, RIFAPENTINE AND FCE-22807, IN EXPERIMENTAL MURINE TUBERCULOSIS [J].
DHILLON, J ;
DICKINSON, JM ;
GUY, JA ;
NG, TK ;
MITCHISON, DA .
TUBERCLE AND LUNG DISEASE, 1992, 73 (02) :116-123
[3]   ASSAY OF RIFAMPICIN IN SERUM [J].
DICKINSON, JM ;
ABER, VR ;
ALLEN, BW ;
ELLARD, GA ;
MITCHISON, DA .
JOURNAL OF CLINICAL PATHOLOGY, 1974, 27 (06) :457-462
[4]   EFFICACY OF INTERMITTENT PYRAZINAMIDE IN EXPERIMENTAL MURINE TUBERCULOSIS [J].
DICKINSON, JM ;
MITCHISON, DA .
TUBERCLE, 1991, 72 (02) :110-114
[5]  
ELLARD G A, 1969, Tubercle, V50, P144, DOI 10.1016/0041-3879(69)90020-8
[6]   OBSERVATIONS ON REDUCTION OF RENAL ELIMINATION OF URATE IN MAN CAUSED BY ADMINISTRATION OF PYRAZINAMIDE [J].
ELLARD, GA ;
HASLAM, RM .
TUBERCLE, 1976, 57 (02) :97-103
[7]  
ELLARD GA, 1986, AM REV RESPIR DIS, V133, P1076
[8]  
Fox W., 1990, Indian Journal of Tuberculosis, V37, P175
[9]   DRUG-COMBINATIONS AND THE BIOAVAILABILITY OF RIFAMPICIN [J].
FOX, W .
TUBERCLE, 1990, 71 (04) :241-245
[10]   ANTAGONISM BETWEEN ISONIAZID AND THE COMBINATION PYRAZINAMIDE-RIFAMPIN AGAINST TUBERCULOSIS INFECTION IN MICE [J].
GROSSET, J ;
TRUFFOTPERNOT, C ;
LACROIX, C ;
JI, B .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (03) :548-551